CSL Behring, the world’s 3rd largest biotechnology company, is leveraging our regulated BrightInsight Platform to manage and support its growing digital health portfolio of solutions focused on enhancing the treatment experiences of patients with rare and serious diseases.
Kalkin Media - May 29, 2020
MedCity News - May 11, 2020
Sep 23, 2020 - Sep 24, 2020
The 2nd annual BrightInsight Ecosystem Event will bring together some of the industry's top minds to explore real-world digital health use cases, discuss best-practices for moving from pilot to scale and share how to accelerate digital innovation within biopharma and medtech companies.
Feb 18, 2020 - Feb 20, 2020
BrightInsight's Sr. Director of Commercial, Paul Schultz participated in a panel discussion: What's going to stop Digital Therapeutics from Breaking Big.
Jan 13, 2020
BrightInsight will be hosting our 3rd Annual Digital Health Panel at JP Morgan’s Healthcare Conference. This year's panel will dig deeper than what’s on the surface to understand how the world’s top biopharma and medtech companies are investing in digital, discuss how to partner with digital therapeutics and technology leaders and how to disrupt traditional organizations from within.